Cyagen is prioritizing production of ACE2 mice to support research on COVID-19, the disease caused by SARS-CoV-2 virus. Effective immediately, we are opening orders for select ACE2 mouse ... Read More ›

If you are considering applying for a grant, reviewers will seek to understand the strategies used in generating any research models for your proposal. Cyagen’s model generation experts ... Read More ›

Cyagen offers high quality and reliable research-use cell products to researchers around the world. Until now, Cyagen's products have been referenced in over 1,200 customer publications, cited by ... Read More ›

Take advantage of our Cryopreservation and Breeding services to save time, space and money. Read More ›

With highly competitive pricing, backed by a 100% money-back guarantee. Read More ›

Get your single copy transgenic mice in as little as 3 months. Read More ›

In our continuing efforts to expand the gene knockout models offered in the Cyagen Knockout Catalog, described in our recent Technical Bulletin, we are proud to announce the ... Read More ›

What is the first thing that comes to your mind when we mention ‘safe harbor’? The ‘safe harbor’ we want to talk about today is not the kind ... Read More ›

With the gradual improvement of the COVID-19 situation in China in the past few days, along with a worsening situation across many regions, research on vaccines and related ... Read More ›

Since COVID-19 poses a significant threat to public health and also represents a challenge for antiviral drug development and administration globally, current efforts focus on prevention and control ... Read More ›

With the rapid advancement of biomedical technology in recent years, customized treatment methods such as targeted medicine, immunotherapy, and gene therapy have become the main directions of biomedical ... Read More ›

Cyagen is proud to announce the availability of BALB/c mouse models for all embryonic stem cell (ESC) based gene targeting services, including our proprietary TurboKnockout^® technology. Read More ›